Delhi HC sets aside Centre’s decision to ban 344 fixed dose combination drugs

By Akanksha Jain, The Hindu| December 1, 2016

In a major development and big relief to pharma majors, the Delhi High Court on Thursday set aside the Union government’s decision to ban 344 fixed-dose combination (FDC) drugs, including well known names like Corex, a cough syrup, Vicks Action 500 and D’Cold.

What is a fixed-dose combination?
  • An FDC is one that contains two or more drugs combined in a fixed ratio of doses and available in a single dosage form.

The Centre’s decision was challenged by Pfizer, Glenmark, Procter & Gamble, Cipla and some NGOs.

The government had banned the drugs on the grounds that they involve “risk” to humans and safer alternatives were available.
Advertisements
This entry was posted in Uncategorized and tagged . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s